• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞表面膜结合型和脱落型低密度脂蛋白受体相关蛋白 1 对细胞外组织金属蛋白酶抑制剂 3 水平的差异调节。

Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.

机构信息

Department of Medicine, Imperial College London, London SW7 2AZ, United Kingdom.

出版信息

J Biol Chem. 2013 Jan 4;288(1):332-42. doi: 10.1074/jbc.M112.393322. Epub 2012 Nov 19.

DOI:10.1074/jbc.M112.393322
PMID:23166318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3537031/
Abstract

Tissue inhibitor of metalloproteinases-3 (TIMP-3) plays a key role in regulating extracellular matrix turnover by inhibiting matrix metalloproteinases (MMPs), adamalysins (ADAMs), and adamalysins with thrombospondin motifs (ADAMTSs). We demonstrate that levels of this physiologically important inhibitor can be regulated post-translationally by endocytosis. TIMP-3 was endocytosed and degraded by a number of cell types including chondrocytes, fibroblasts, and monocytes, and we found that the endocytic receptor low density lipoprotein receptor-related protein-1 (LRP-1) plays a major role in TIMP-3 internalization. However, the cellular uptake of TIMP-3 significantly slowed down after 10 h due to shedding of LRP-1 from the cell surface and formation of soluble LRP-1 (sLRP-1)-TIMP-3 complexes. Addition of TIMP-3 to HTB94 human chondrosarcoma cells increased the release of sLRP-1 fragments of 500, 215, 160, and 110 kDa into the medium in a concentration-dependent manner, and all of these fragments were able to bind to TIMP-3. TIMP-3 bound to sLRP-1, which was resistant to endocytosis, retained its inhibitory activity against metalloproteinases. Extracellular levels of sLRP-1 can thus increase the half-life of TIMP-3 in the extracellular space, controlling the bioavailability of TIMP-3 to inhibit metalloproteinases.

摘要

组织金属蛋白酶抑制剂 3(TIMP-3)通过抑制基质金属蛋白酶(MMPs)、解整合素金属蛋白酶(ADAMs)和含血栓反应蛋白基序的解整合素金属蛋白酶(ADAMTSs)在调节细胞外基质的周转中发挥关键作用。我们证明,这种具有生理重要性的抑制剂的水平可以通过内吞作用进行翻译后调节。TIMP-3 被包括软骨细胞、成纤维细胞和单核细胞在内的多种细胞类型内吞和降解,我们发现内吞受体低密度脂蛋白受体相关蛋白-1(LRP-1)在 TIMP-3 的内化中起主要作用。然而,由于细胞表面 LRP-1 的脱落和可溶性 LRP-1(sLRP-1)-TIMP-3 复合物的形成,TIMP-3 的细胞摄取在 10 小时后显著减慢。将 TIMP-3 添加到 HTB94 人软骨肉瘤细胞中,以浓度依赖的方式增加了 500、215、160 和 110 kDa 的 sLRP-1 片段进入培养基中的释放,并且所有这些片段都能够与 TIMP-3 结合。TIMP-3 与 sLRP-1 结合,sLRP-1 不能被内吞,仍然保持对金属蛋白酶的抑制活性。因此,细胞外 sLRP-1 的水平可以增加 TIMP-3 在细胞外空间的半衰期,控制 TIMP-3 抑制金属蛋白酶的生物利用度。

相似文献

1
Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.细胞表面膜结合型和脱落型低密度脂蛋白受体相关蛋白 1 对细胞外组织金属蛋白酶抑制剂 3 水平的差异调节。
J Biol Chem. 2013 Jan 4;288(1):332-42. doi: 10.1074/jbc.M112.393322. Epub 2012 Nov 19.
2
Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.剖析金属蛋白酶组织抑制剂-3(TIMP-3)与低密度脂蛋白受体相关蛋白-1(LRP-1)之间的相互作用:开发一种“TRAP”以提高组织中TIMP-3的水平。
Matrix Biol. 2017 May;59:69-79. doi: 10.1016/j.matbio.2016.07.004. Epub 2016 Jul 29.
3
TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.TIMP-3 促进靶金属蛋白酶与内吞受体 LRP-1 的结合,并促进 MMP-1 的清除。
Sci Rep. 2020 Jul 21;10(1):12067. doi: 10.1038/s41598-020-69008-9.
4
Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.TIMP-3 表达增加通过双重抑制金属蛋白酶 ADAM10 和 LRP-1 受体的配体结合来改变细胞的细胞外分泌组。
Sci Rep. 2018 Oct 2;8(1):14697. doi: 10.1038/s41598-018-32910-4.
5
Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3.硫酸化糖胺聚糖控制金属蛋白酶抑制剂TIMP-3的细胞外运输和活性。
Chem Biol. 2014 Oct 23;21(10):1300-1309. doi: 10.1016/j.chembiol.2014.07.014. Epub 2014 Aug 28.
6
Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.对胞吞作用具有抗性的工程化金属蛋白酶组织抑制剂-3变体具有延长的软骨保护活性。
J Biol Chem. 2016 Oct 14;291(42):22160-22172. doi: 10.1074/jbc.M116.733261. Epub 2016 Aug 31.
7
Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities.低密度脂蛋白受体相关蛋白-1介导金属蛋白酶组织抑制剂-1的内吞清除并促进其细胞因子样活性。
PLoS One. 2014 Jul 30;9(7):e103839. doi: 10.1371/journal.pone.0103839. eCollection 2014.
8
Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.低密度脂蛋白受体相关蛋白通过一种不依赖血小板反应蛋白的机制介导前基质金属蛋白酶-2·基质金属蛋白酶组织抑制因子-2复合物的内吞清除。
J Biol Chem. 2004 Dec 24;279(52):54944-51. doi: 10.1074/jbc.M406792200. Epub 2004 Oct 15.
9
MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1.基质金属蛋白酶-13在人软骨细胞中组成性产生,并通过内吞受体低密度脂蛋白受体相关蛋白1(LRP1)与含血小板反应蛋白基序的解聚素样金属蛋白酶-5(ADAMTS-5)和金属蛋白酶组织抑制因子-3(TIMP-3)共同内吞。
Matrix Biol. 2016 Dec;56:57-73. doi: 10.1016/j.matbio.2016.03.007. Epub 2016 Apr 12.
10
Shedding of low-density lipoprotein receptor–related protein-1 in acute respiratory distress syndrome.急性呼吸窘迫综合征中 LDL 受体相关蛋白-1 的脱落。
Am J Respir Crit Care Med. 2011 Aug 15;184(4):438-48. doi: 10.1164/rccm.201009-1422OC.

引用本文的文献

1
LRP1 Shedding in Ricin-Induced Lung Injury: A Cell-Specific Response to Toxin Exposure.蓖麻毒素诱导的肺损伤中LRP1的脱落:对毒素暴露的细胞特异性反应。
Int J Mol Sci. 2025 Jun 6;26(12):5448. doi: 10.3390/ijms26125448.
2
LRP1 Mediates Endocytosis Activity and Is a Potential Therapeutic Target in Osteoarthritis.低密度脂蛋白受体相关蛋白1介导内吞活性,是骨关节炎的一个潜在治疗靶点。
Orthop Surg. 2025 Jun;17(6):1604-1619. doi: 10.1111/os.70035. Epub 2025 Apr 2.
3
LRP1 mitigates intervertebral disc degeneration by inhibiting endoplasmic reticulum stress through stabilizing the PPARγ.低密度脂蛋白受体相关蛋白1(LRP1)通过稳定过氧化物酶体增殖物激活受体γ(PPARγ)抑制内质网应激,从而减轻椎间盘退变。
J Orthop Translat. 2025 Jan 16;50:196-210. doi: 10.1016/j.jot.2024.12.009. eCollection 2025 Jan.
4
Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.骨骼祖细胞LRP1缺乏会导致严重且持续的骨骼缺陷,并伴有Wnt信号通路失调。
Bone Res. 2025 Jan 26;13(1):17. doi: 10.1038/s41413-024-00393-x.
5
Transcriptomic and functional characterization of megakaryocytic-derived platelet-like particles: impaired aggregation and prominent anti-tumor effects.巨核细胞衍生的血小板样颗粒的转录组学和功能特征:聚集受损和显著的抗肿瘤作用。
Platelets. 2025 Dec;36(1):2449344. doi: 10.1080/09537104.2024.2449344. Epub 2025 Jan 15.
6
Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17.用于鉴定ADAM17硫酸乙酰肝素蛋白聚糖结合底物的蛋白质组学工作流程的开发
Proteomics. 2024 Dec;24(23-24):e202400076. doi: 10.1002/pmic.202400076. Epub 2024 Sep 24.
7
Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.综述:Sorsby 眼底营养不良中 TIMP-3 积累的机制和发病机制。
Mol Vis. 2024 Mar 3;30:74-91. eCollection 2024.
8
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.靶向聚集素酶治疗骨关节炎:从锌螯合到外位点抑制。
J Med Chem. 2022 Oct 27;65(20):13505-13532. doi: 10.1021/acs.jmedchem.2c01177. Epub 2022 Oct 17.
9
High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of Chondrosarcoma.化学性缺氧处理细胞的高分辨率分泌蛋白质组分析鉴定出软骨肉瘤的潜在生物标志物。
Proteomes. 2022 Jul 20;10(3):25. doi: 10.3390/proteomes10030025.
10
Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.解析 TIMP2 在癌症中的独特生物学功能和潜在治疗应用。
Carcinogenesis. 2022 Jun 4;43(5):405-418. doi: 10.1093/carcin/bgac037.

本文引用的文献

1
HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.高迁移率族蛋白 B1 通过增强心脏再生和 miR-206 介导的 TIMP-3 抑制减轻衰竭心脏中的心脏重构。
PLoS One. 2011;6(6):e19845. doi: 10.1371/journal.pone.0019845. Epub 2011 Jun 22.
2
Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.细胞胆固醇调节依赖于金属蛋白酶的低密度脂蛋白受体相关蛋白-1(LRP-1)的脱落及其清除功能。
FASEB J. 2011 Aug;25(8):2770-81. doi: 10.1096/fj.10-169508. Epub 2011 Apr 25.
3
Shedding of low-density lipoprotein receptor–related protein-1 in acute respiratory distress syndrome.急性呼吸窘迫综合征中 LDL 受体相关蛋白-1 的脱落。
Am J Respir Crit Care Med. 2011 Aug 15;184(4):438-48. doi: 10.1164/rccm.201009-1422OC.
4
Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.硫酸乙酰肝素蛋白聚糖和低密度脂蛋白受体相关蛋白 1 构成了神经元淀粉样β摄取的主要途径。
J Neurosci. 2011 Feb 2;31(5):1644-51. doi: 10.1523/JNEUROSCI.5491-10.2011.
5
Tissue factor pathway inhibitor endocytosis.组织因子途径抑制剂内吞作用。
Trends Cardiovasc Med. 1997 Oct;7(7):234-9. doi: 10.1016/S1050-1738(97)00083-2.
6
A single lysine of the two-lysine recognition motif of the D3 domain of receptor-associated protein is sufficient to mediate endocytosis by low-density lipoprotein receptor-related protein.D3 结构域受体相关蛋白的双赖氨酸识别基序中的一个赖氨酸足以介导低密度脂蛋白受体相关蛋白的内吞作用。
Int J Biochem Cell Biol. 2011 Mar;43(3):431-40. doi: 10.1016/j.biocel.2010.11.017. Epub 2010 Dec 7.
7
Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages.炎症介质促进 LRP1/CD91 的脱落产生,后者调节巨噬细胞的细胞信号转导和细胞因子表达。
J Leukoc Biol. 2010 Oct;88(4):769-78. doi: 10.1189/jlb.0410220. Epub 2010 Jul 7.
8
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.金属蛋白酶组织抑制剂(TIMPs):一个具有结构和功能多样性的古老家族。
Biochim Biophys Acta. 2010 Jan;1803(1):55-71. doi: 10.1016/j.bbamcr.2010.01.003. Epub 2010 Jan 15.
9
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.TGFbeta 介导的肝 miR-181b 上调通过靶向 TIMP3 促进肝癌发生。
Oncogene. 2010 Mar 25;29(12):1787-97. doi: 10.1038/onc.2009.468. Epub 2009 Dec 21.
10
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.撤回:miR-221和miR-222通过下调PTEN和TIMP3来调节TRAIL抗性并增强肿瘤发生能力。
Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.